Latest news with #LisaNelson
Yahoo
28-05-2025
- Business
- Yahoo
CBD Life Sciences Inc. (CBDL) Announces New Powerful 500MG THC Delta-8 Gummy
With Delta-8 product revenue continuing to climb, CBDL introduces a lab-tested gummy formulation to meet surging demand in a market projected to exceed $2.1 billion by 2026. SCOTTSDALE, AZ / / May 28, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a rising force in the cannabinoid wellness industry, is proud to announce the latest addition to its growing Delta-8 product lineup: a premium, lab-tested Delta-8 THC gummy, developed in-house to ensure consistency, potency, and quality at every step. Building on the success of its existing Delta-8 offerings, this new gummy marks another strategic milestone in CBDL's mission to dominate the cannabinoid edibles market. Crafted in a controlled lab environment, this new edible is designed for consumers who prioritize quality, effectiveness, and a clean, smooth Delta-8 experience. "We've already seen strong performance across our Delta-8 line, and this gummy is a direct response to customer demand for more convenient, enjoyable, and effective ways to experience its benefits," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "As always, we're delivering a product that's backed by science, produced in-house, and driven by results." Delta-8 THC: Expanding the Future of Functional WellnessUnlike traditional Delta-9 THC, Delta-8 offers a milder, clearer psychoactive experience - making it a preferred option for wellness seekers, first-time users, and individuals looking for a balanced high without anxiety. CBDL's newly formulated Delta-8 gummies are not just about effect - they're designed to deliver real therapeutic value. Below is a breakdown of the core wellness benefits supported by research and consumer feedback: Pain Relief • Engages the endocannabinoid system to help regulate pain• May reduce inflammation that contributes to chronic discomfort Anxiety & Stress Support • Natural calming effects to help manage daily stress and reduce anxiety• Promotes overall mood balance without sedation Nausea Control • Anti-emetic potential makes it a powerful option for those undergoing chemotherapy or other nausea-inducing treatments Appetite Stimulation • Ideal for individuals with appetite loss or dietary imbalances related to health conditions Neuroprotective Potential • Early research suggests Delta-8 THC may contribute to long-term brain health through its interaction with CB1 receptors Made In-House. Backed by Lab many mass-produced gummies on the market, CBDL maintains full control over every phase - from formulation to packaging - in its in-house manufacturing facility. Each batch is independently lab-tested to guarantee purity, potency, and compliance, giving consumers complete confidence in what they're consuming. Strategic Growth for Shareholders & StakeholdersDelta-8 THC products have already proven to be one of CBDL's strongest performing categories, and this launch further solidifies the company's aggressive expansion in the high-growth cannabinoid edible space. The market for Delta-8 continues to gain national momentum, with sales projections showing compound annual growth that far outpaces many traditional supplement sectors. "This gummy is just one part of a much larger product ecosystem we're building - focused on in-demand cannabinoids, real health outcomes, and market scalability," said Nelson. Product Details • Product: Delta-8 THC Gummy• Type: Vegan, In-House Formulated, Lab-Tested• MG per Gummy: 500MG• Availability: Launching via Flavors: Blue Razz & Strawberry About CBD Life Sciences Inc. (CBDL)CBD Life Sciences Inc. is a vertically integrated health and wellness company focused on cannabinoid innovation. With a robust pipeline of CBD, Delta-8, and other hemp-derived formulations, CBDL operates across direct-to-consumer, retail, and wholesale channels - including recent distribution on Walmart Marketplace and additional platforms coming soon. Follow our social media for the latest updates!X: Contact: cbdvaultaz@ Stay Connected & Be the First to Try Our New Functional Mushroom Products! Mushroom Madness Instagram: Mushroom Madness Website: Forward-Looking StatementsExcept for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Safe Harbor StatementThis release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements. Contact InformationLisa NelsonCEOcbdvaultaz@ SOURCE: CBD Life Sciences Inc. View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
06-05-2025
- Business
- Yahoo
CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company
Strategic alliance positions CBDL for aggressive national growth through 100+ retail locations and new premium product lines SCOTTSDALE, AZ / ACCESS Newswire / May 6, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the CBD health and wellness space, is proud to announce a new strategic manufacturing partnership with Jeannie in a Bottle, a fast-growing Arizona-based CBD company with a national retail footprint. This powerful collaboration will see CBDL formulating and manufacturing top-tier CBD products for Jeannie in a Bottle - a company with proven market traction and shelf presence in over 100 gas stations and convenience stores across the United States. The deal expands CBDL's manufacturing portfolio while opening the door to high-volume, recurring product orders tied to Jeannie's established consumer base and retail distribution network. Under this agreement, CBDL will take full control of the production, packaging, and labeling of a specialized line of high-potency CBD products exclusively for Jeannie in a Bottle - a strategic move expected to significantly boost CBDL's nationwide revenue stream through consistent retail orders and brand expansion. "This partnership is a win-win - not just for CBDL and Jeannie in a Bottle, but for shareholders and customers alike," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We're stepping into a high-velocity retail environment with a proven brand, and bringing our own formulation and production strengths to the table. This is the kind of alignment that accelerates revenue, reputation, and results." With CBDL managing product development, formulation, and manufacturing, Jeannie in a Bottle is positioned to scale its product offerings faster than ever - offering convenience store customers across the country consistent, compliant, and highly effective CBD wellness solutions. Why This Deal Matters for CBDL Investors:
Associated Press
22-04-2025
- Health
- Associated Press
CBD Life Sciences Inc. (CBDL) Announces Groundbreaking 100MG Full Spectrum CBD Gummy Geared Toward Mental Health & Focus
With the global CBD market expected to exceed $60 billion by 2030, and the mental wellness industry surging past $500 billion, CBD Life Sciences Inc. (OTC:CBDL) is strategically positioning itself at the center of two of the fastest-growing markets in modern health. SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) a leader in cannabinoid-driven health innovation - proudly announces the launch of its most anticipated product to date: a high-dosage 100MG Full Spectrum CBD Gummy, meticulously formulated to support mental health, daily focus, and emotional well-being. Available in mouth-watering Crisp Green Apple and Wild Blueberry flavors, this isn't your average CBD gummy. It's a next-generation wellness tool - designed not only to relax the body but to sharpen the mind. Crafted with full-spectrum cannabinoids, these gummies are being positioned as a natural ally in the pursuit of mental clarity, balance, and daily productivity. 'Mental health isn't a trend - it's a global crisis. And people are tired of band-aid solutions,' said Lisa Nelson, President & CEO of CBD Life Sciences Inc. 'This product was built to empower people who want to feel better and function better - without the side effects of traditional pharmaceuticals. It's a powerful, natural alternative that speaks directly to the stress, anxiety, and attention struggles millions face every day.' Lab tested and verified with Certificates of Analysis (COAs), this 100MG gummy represents the company's deepest push yet into the lucrative mental wellness category. Unlike many low-dose competitors, CBDL's bold formulation is made for people who need real results - entrepreneurs, creatives, students, parents, and professionals looking to stay in control of their mood and mindset. Early conversations with several wellness clinics and mental health centers are already in progress, exploring how this high-potency gummy could be integrated into patient routines. While no formal agreements have been made, the demand is clear: health professionals are actively seeking natural, high-quality, lab-verified CBD options to complement modern mental wellness protocols. CBDL is rapidly building a portfolio that taps into high-value niches: from pain relief and nano-enhanced beverages to functional CBD coffee creamers and now, this cutting-edge product for mental clarity. The company's ability to stay ahead of trends and deliver results has attracted attention from both investors and the wellness industry. 'We're not trying to follow the market - we're reshaping it,' Nelson added. 'With this launch, we're doubling down on our belief that the future of wellness lies in functional, focused, and effective cannabinoid products.' This release is a bold statement to shareholders and the industry: CBD Life Sciences Inc. is serious about mental health. The company's momentum continues to build, and with this new launch, they're inviting wellness professionals, retail buyers, and everyday users to experience the next level of what CBD can offer. The 100MG Mental Health Gummies are available now, with full lab reports and wholesale interest forms available on the company's website. For product information, COAs, or wholesale inquiries, please visit About CBD Life Sciences Inc. CBD Life Sciences Inc. (CBDL) is a leading innovator in the wellness and alternative health sector, specializing in high-quality CBD and functional mushroom products designed to enhance well-being. With a commitment to scientific research and consumer safety, CBDL continues to push the boundaries of holistic health solutions, creating opportunities for exponential growth in a rapidly evolving market. Follow our social media for the latest updates! X: Instagram: IR Contact: [email protected] Stay Connected & Be the First to Try Our New Functional Mushroom Products! Mushroom Madness Instagram: Mushroom Madness Website: Forward-Looking Statements Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Safe Harbor Statement This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements. Contact Information Lisa Nelson CEO [email protected] 4802091720 SOURCE: CBD Life Sciences, Inc. press release
Associated Press
27-03-2025
- Business
- Associated Press
CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex - A Powerful Sexual Enhancement Supplement
The global sexual wellness market is projected to surpass $125 billion by 2026, with the supplement industry experiencing rapid growth as consumers seek natural solutions for enhanced performance and vitality. SCOTTSDALE, AZ / ACCESS Newswire / March 27, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making waves in the booming health and wellness industry with the launch of its latest breakthrough product: Passion Fuel Cordyceps Complex. This cutting-edge supplement is designed to supercharge libido, enhance stamina, improve blood flow, and optimize overall performance, providing an all-natural solution for individuals looking to elevate their intimate and athletic experiences. Each serving of Passion Fuel Cordyceps Complex delivers a potent 300mg dose of pure Cordyceps extract (150mg per pill, 2 pills per serving)-a revered medicinal mushroom known for its powerful adaptogenic properties. Backed by scientific research, Cordyceps has been shown to increase oxygen uptake, improve circulation, boost testosterone levels, and enhance endurance, making it a game-changer for those seeking peak physical and sexual performance. 'This launch is a major milestone for CBDL as we continue to expand our product line with high-demand, science-backed formulations,' said Lisa Nelson, President & CEO of CBD Life Sciences Inc. 'With the sexual wellness market projected to skyrocket past $125 billion, we are positioning ourselves at the forefront of an industry that is set to redefine natural health solutions. Passion Fuel Cordyceps Complex has the potential to generate significant revenue streams and open the door to lucrative partnerships in both the supplement and pharmaceutical sectors.' Unleashing the Power of Cordyceps for Peak Performance Passion Fuel Cordyceps Complex offers a wide range of benefits, including: Enhanced libido & improved erectile function - Naturally increases testosterone and supports sexual health. Boosted stamina & athletic performance - Increases ATP production, delivering sustained energy and endurance. Improved blood flow & circulation - Supports heart health and oxygenation for peak physical function. Optimized hormonal balance - Helps regulate cortisol and stress levels, fostering overall well-being. Increased energy & vitality - Fights fatigue and enhances metabolic efficiency for all-day performance. A Strategic Move for Future Growth The release of Passion Fuel Cordyceps Complex aligns with CBDL's aggressive expansion strategy, tapping into an industry that continues to experience unprecedented demand. With the dietary supplement market exceeding $177 billion in 2023, CBDL is capitalizing on a golden opportunity to deliver premium, plant-based formulations that consumers trust. As the company accelerates its growth trajectory, Passion Fuel Cordyceps Complex is set to be distributed across major online marketplaces, wellness retailers, and direct-to-consumer platforms. CBDL is also actively exploring strategic partnerships to bring this powerhouse supplement to new audiences globally. About CBD Life Sciences Inc. CBD Life Sciences Inc. (OTC: CBDL) is a leader in the rapidly expanding health and wellness industry, specializing in cutting-edge CBD-based and plant-derived formulations. With a commitment to innovation and quality, CBDL continues to develop science-backed products designed to optimize health, performance, and longevity. X: Stay Connected & Be the First to Try Our New Functional Mushroom Products! Forward-Looking Statements Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Safe Harbor Statement This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements. CEO 4802091720
Associated Press
25-03-2025
- Business
- Associated Press
CBD Life Sciences Inc. (CBDL) Gears Up for Cave Creek Bike Week 2025
CBDL Targets a Multi-Million Dollar Market as Tens of Thousands of Attendees Converge for Arizona's Hottest Motorcycle Event SCOTTSDALE, AZ / ACCESS Newswire / March 25, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a market leader in the CBD and mushroom wellness industry, is revving up for its high-octane presence at the legendary Cave Creek Bike Week, March 28 - April 6, 2025. With tens of thousands of motorcycle enthusiasts and thrill-seekers converging on Cave Creek, this premier event presents an unparalleled opportunity for CBDL to showcase its groundbreaking product line, maximize brand visibility, and generate explosive revenue growth. Cave Creek Bike Week, hosted by the Hideaway Grill and Roadhouse, has become a nationally recognized gathering of riders, industry professionals, and lifestyle brands. The 2024 event boasted record attendance, featuring jaw-dropping stunt shows, live music, exclusive vendors, and premium entertainment. The Hideaway Grill is located at 6746 E Cave Creek Rd, Cave Creek, AZ 85331. While exact figures for Cave Creek Bike Week remain undisclosed, it coincides with Arizona Bike Week, which reported an astonishing 85,000 attendees in 2023. With attendees typically spending hundreds of dollars per visit on lifestyle and wellness products, this event represents a major revenue catalyst for participating businesses. Estimates suggest that Arizona Bike Week alone generates upwards of $20 million in local economic impact, a number that underscores the lucrative potential for vendors like CBDL. By tapping into this high-spending demographic, CBDL is strategically positioned to capitalize on the surging demand for premium wellness solutions. CBDL's subsidiary, Mushroom Madness, will take center stage with a high-visibility tent at the Horny Toad Restaurant, located at 6738 E Cave Creek Rd, Cave Creek, AZ 85331. This prime location ensures maximum foot traffic and engagement, giving attendees direct access to an exclusive selection of CBDL's cutting-edge products, including: 3000MG CBD Pain Relief Cream - A best-seller now featured on Walmart Marketplace, designed to deliver fast, long-lasting relief for muscle and joint pain. Mellow Mornings CBD Coffee Creamer - A revolutionary nano-CBD infused creamer providing up to 10x bioavailability for stress-free mornings. Functional Mushroom Supplements - Featuring Reishi, Lion's Mane, and Ashwagandha, formulated to enhance cognitive function, reduce stress, and support immunity. Kava & Kratom Energy Shots - A breakthrough in plant-based energy and relaxation, catering to alternative wellness enthusiasts. 'We see Cave Creek Bike Week as a monumental revenue driver and a launchpad for even greater market penetration,' said Lisa Nelson, CEO of CBD Life Sciences Inc. 'This event places us directly in front of a massive consumer base that aligns perfectly with our brand - people who prioritize performance, endurance, and natural wellness. With our growing presence in retail and e-commerce, this is the perfect moment for investors to take notice of CBDL's rapid expansion.' CBDL's participation aligns with its aggressive growth strategy, leveraging high-traffic events to drive direct-to-consumer sales, brand loyalty, and shareholder value. With increasing product adoption and expanding retail partnerships, the company is poised for continued revenue acceleration in 2025. For more information about CBD Life Sciences Inc. and its participation in Cave Creek Bike Week, please visit About CBD Life Sciences Inc. CBD Life Sciences Inc. (CBDL) is an industry leader in health and wellness, specializing in premium CBD and functional mushroom-based products. Through its subsidiaries, including Mushroom Madness, the company provides high-quality, scientifically formulated wellness solutions designed to enhance daily life. With a commitment to innovation, expansion, and shareholder growth, CBDL continues to push boundaries in the rapidly evolving alternative wellness market. Note: The attendance figures mentioned pertain to Arizona Bike Week and are provided for contextual purposes. Actual attendance at Cave Creek Bike Week may vary. Stay Connected & Be the First to Try Our New Functional Mushroom Products! Forward-Looking Statements Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Safe Harbor Statement This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements. CEO 4802091720 SOURCE: CBD Life Sciences, Inc.
